Literature DB >> 19291393

Memantine prevents sensitivity to excitotoxic cell death of rat cortical neurons expressing human truncated tau protein.

Martin Cente1, Stanislava Mandakova, Peter Filipcik.   

Abstract

We have previously shown that human misfolded tau proteins strongly perturb mitochondrial transport and induce accumulation of free radicals in neurons. This interference is underlying cause of increased susceptibility to oxidative stress and could be linked to excitotoxic pathways. In order to understand integral mechanisms of misfolded tau driven neurodegeneration, we have investigated the role of human truncated tau protein, derived from Alzheimer's disease, in rat cortical neurons under the conditions of excitotoxic stress induced by glutamate. We found that primary neurons expressing truncated tau protein are highly susceptible to glutamate-induced cell death. Pre-treatment with memantine (N-methyl-D-aspartate receptor antagonist) significantly improved survival of rat neurons exposed to glutamate and its effect was associated with overall decrease of reactive oxygen species (ROS) in both transgenic and nontransgenic neurons. Interestingly, despite of this overall effect, memantine was not able to decrease misfolded tau-induced ROS level specifically in transgenic cells. Our data suggest that memantine does not interfere with specific pathological pathways induced by misfolded tau protein nevertheless is able to attenuate oxidative stress in neurons.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19291393     DOI: 10.1007/s10571-009-9379-1

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  32 in total

Review 1.  Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.

Authors:  D A Butterfield; J Drake; C Pocernich; A Castegna
Journal:  Trends Mol Med       Date:  2001-12       Impact factor: 11.951

Review 2.  Tau, tangles, and Alzheimer's disease.

Authors:  Lester I Binder; Angela L Guillozet-Bongaarts; Francisco Garcia-Sierra; Robert W Berry
Journal:  Biochim Biophys Acta       Date:  2005-01-03

Review 3.  Calcium dysregulation in Alzheimer's disease.

Authors:  Lukasz Bojarski; Jochen Herms; Jacek Kuznicki
Journal:  Neurochem Int       Date:  2007-10-05       Impact factor: 3.921

Review 4.  Adverse psychological impact, glutamatergic dysfunction, and risk factors for Alzheimer's disease.

Authors:  T Myhrer
Journal:  Neurosci Biobehav Rev       Date:  1998       Impact factor: 8.989

5.  Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation.

Authors:  Jillian J Kril; Smita Patel; Antony J Harding; Glenda M Halliday
Journal:  Acta Neuropathol       Date:  2001-12-12       Impact factor: 17.088

6.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Authors:  I Grundke-Iqbal; K Iqbal; Y C Tung; M Quinlan; H M Wisniewski; L I Binder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 7.  Memantine: a therapeutic approach in treating Alzheimer's and vascular dementia.

Authors:  Horst J Koch; Gökhan Uyanik; David Fischer-Barnicol
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2005-10

8.  Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease.

Authors:  Francisco García-Sierra; Nupur Ghoshal; Bruce Quinn; Robert W Berry; Lester I Binder
Journal:  J Alzheimers Dis       Date:  2003-04       Impact factor: 4.472

Review 9.  Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases.

Authors:  A Cristina Rego; Catarina R Oliveira
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

10.  Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.

Authors:  David Wilkinson; Henning Friis Andersen
Journal:  Dement Geriatr Cogn Disord       Date:  2007-07-04       Impact factor: 2.959

View more
  3 in total

1.  Protection from glutamate-induced excitotoxicity by memantine.

Authors:  Melinda K Kutzing; Vincent Luo; Bonnie L Firestein
Journal:  Ann Biomed Eng       Date:  2011-12-28       Impact factor: 3.934

2.  Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans.

Authors:  Petronela Weisová; Ondrej Cehlár; Rostislav Škrabana; Monika Žilková; Peter Filipčík; Branislav Kováčech; Michal Prčina; Ľubica Wojčiaková; Ľubica Fialová; Tomáš Smolek; Eva Kontseková; Norbert Žilka; Michal Novák
Journal:  Acta Neuropathol Commun       Date:  2019-08-07       Impact factor: 7.801

3.  Inhibition of CK2 mitigates Alzheimer's tau pathology by preventing NR2B synaptic mislocalization.

Authors:  Courtney A Marshall; Jennifer D McBride; Lakshmi Changolkar; Dawn M Riddle; John Q Trojanowski; Virginia M-Y Lee
Journal:  Acta Neuropathol Commun       Date:  2022-03-04       Impact factor: 7.801

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.